Drugmaker&#39;s stocks fall after FDA researcher wonders about 5 drugs
88351
Dr David Graham told a Senate panel that five well known drugs, which are currently on the market, needed to be looked at more closely - this sent share values down for many drug companies.
224503
Shionogi Co. shares fell as much as 14.4 percent in Tokyo on concerns in the European Union and US about the safety of Crestor, a cholesterol-reducing drug developed by the Japanese company and sold by AstraZeneca Plc.
529988
Shares of Indianapolis-based drugmaker Eli Lilly and Co. , maker of antidepressant drug Prozac, nudged nearly 1 percent lower on Friday.
489823
Shares in Pfizer Inc, the world's biggest drugmaker, fell more than 10 percent in early trade in Europe on Monday, after news it had scrapped its most important experimental drug.
275318
Shares of Merck &amp; Co. (MRK.N: Quote, Profile, Research) fell on Thursday after a US study suggested that patients taking its Vioxx arthritis drug had a 50 percent greater risk
384336
Drug makers failed to bounce back from a Thursday slide, with many drug stocks closing down Friday as drug giant Pfizer Inc. and generic drug challenger Alpharma Inc.
372947
Stocks of branded and generic drug makers closed down a bit Tuesday as clinical study results mixed with merger updates. One of the big winners on the day was Nektar Therapeutics, on news that Exubera, the
454431
The drug company's experimental treatment for Alzheimer's  failed to prove effective in a big clinical trial. The stock  closed Tuesday at $45.85 on the New York Stock Exchange before  falling 10 percent in after-hours trading following release of  the trial results.
175709
Investors care more about the drugmaker's future than its Q4 results.
122895
Drug stocks across the board fell amid renewed safety concerns over a class of blockbuster drugs used to treat arthritis. Preprint articles published on the New England Journal of Medicine&#39;s Web site Wednesday
643296
NEW YORK  - Drugs giant Pfizer Inc.&#39;s stock fell on a report that prescriptions for its blockbuster pain medication Celebrex slumped 56 percent last week.
278954
Shares of Eyetech Pharmaceuticals (EYET:Nasdaq - news - research) fell Monday even though several analysts said the company&#39;s experimental eye disease drug Macugen has a good chance of securing government approval.
389867
Shares in Pfizer Inc, the world's  biggest drugmaker, fell more than 10 percent in early trade in  Europe on Monday, after news it had scrapped its most important  experimental drug.
611669
WASHINGTON/NEW YORK  - A U.S. Food and Drug  Administration reviewer who has accused the agency of being lax  in monitoring drug safety on Thursday said five medicines on  the market need closer scrutiny.
180591
Shares of AstraZeneca Plc and GlaxoSmithKline Plc, the UK&#39;s two biggest drugmakers, fell after a US health official said two of their best-selling treatments need closer safety reviews.
414602
Stock falls on news treatment failed a mid-stage trial, company will cease developing drug. NEW YORK  - AtheroGenics Inc.
629222
Investors expecting a formal vote from a Food and Drug Administration panel Friday on Eyetech Pharmaceuticals Inc.&#39;s age-related blindness treatment Macugen may have been disappointed as shares of the stock fell after the meeting.